Guardion Health Sciences, Inc. (GHSI)
NASDAQ: GHSI · IEX Real-Time Price · USD
9.93
-0.04 (-0.43%)
At close: Jul 19, 2024, 4:00 PM
9.86
-0.07 (-0.68%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Guardion Health Sciences Revenue

Guardion Health Sciences had revenue of $12.06M in the twelve months ending March 31, 2024, with 1.79% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $3.00M. In the year 2023, Guardion Health Sciences had annual revenue of $12.25M with 10.85% growth.

Revenue (ttm)
$12.06M
Revenue Growth
+1.79%
P/S Ratio
1.06
Revenue / Employee
$1,340,279
Employees
9
Market Cap
12.75M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202312.25M1.20M10.85%
Dec 31, 202211.05M3.82M52.77%
Dec 31, 20217.23M5.34M282.74%
Dec 31, 20201.89M986.91K109.30%
Dec 31, 2019902.94K-39.22K-4.16%
Dec 31, 2018942.15K504.80K115.42%
Dec 31, 2017437.35K296.32K210.11%
Dec 31, 2016141.03K28.22K25.01%
Dec 31, 2015112.81K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
STRATA Skin Sciences 32.55M
Novo Integrated Sciences 13.52M
Ontrak 12.89M
NEXGEL 4.74M
Addex Therapeutics 1.57M
Avalo Therapeutics 1.45M
Revenue Rankings